Ganymed Robotics

Ganymed Robotics is a French medical technology company founded in 2018 that develops advanced orthopedic robotics. Working closely with leading international surgeons, the company is pioneering a new approach to surgical robotics designed to help clinicians perform faster, more precise, and less invasive interventions. Its mission is to improve patient outcomes, enhance the surgeon's experience, and increase the overall efficiency of joint replacement surgery. The company's core innovation is its "robot with eyes" platform, which augments the surgeon's ability to see beyond the limits of the naked eye and perform precise movements. A custom-designed collaborative robotic arm carries multiple multimodal sensors that can perceive and interpret the surgical scene in an actionable way. The technology platform is intended to enable personalized patient care while avoiding the hassle and invasiveness of cutting guides, optical tracking, and intramedullary rods, and to offer an easy-to-use and cost-effective solution for the growing population of joint replacement patients. Ganymed Robotics announced a breakthrough in markerless robotic technology for patients undergoing knee replacement surgery. The product is still in development and has not been cleared or approved by the U.S. Food and Drug Administration or any other regulatory authority, and is not for sale. Images and descriptions are for illustrative purposes only and reflect a product in preclinical testing. The company is privately held and headquartered in France. Its leadership team includes Frédéric Banégas, Chief Operating Officer and interim Chief Executive Officer, a global strategy and R&D executive with 20 years of experience who has led companies from the startup stage through market and post-market phases, with expertise in AI-driven diagnostic and imaging medical devices and surgical robotics. As a co-founder, he has led diverse international teams across Europe, the United States, China, and Japan, with responsibility for R&D, regulatory, operations, and product development. Clémentine Liard serves as Vice President of Quality Assurance and Regulatory Affairs and Chief of Staff, with 12 years of experience in regulatory affairs and quality assurance in the medical technology industry.

Ganymed Robotics was founded in 2018 in France. From its inception, the company has worked in close collaboration with leading international surgeons to develop a radically new approach to surgical robotics. Its technology is designed to empower clinicians to perform faster, accurate, less invasive interventions. The company's mission is to improve patient outcome, surgeon experience and overall efficiency of joint replacement interventions. It has developed a unique "robot-with-eyes" platform that enhances surgeons' ability to see beyond the naked eye and execute the perfect gesture. A custom-designed co-manipulated arm embarks a wide range of multimodal sensors to perceive and interpret the surgical scene in an actionable manner. Ganymed Robotics aims to provide an easy-to-use and cost-effective solution to better care for the fast-growing number of joint replacement patients. Its technology platform enables surgeons to deliver patient-specific care without the hassle and invasiveness of cutting guides, optical tracking and intra-medullary rods. The company has announced a breakthrough in marker-less robotics for patients with knee replacement surgery. This product is under development and has not been cleared or approved by the U.S. Food and Drug Administration or any other regulatory authority. It is not available for commercial sale, and images and descriptions are for informational purposes only, reflecting a product in pre-clinical testing. As of the available information, Ganymed Robotics remains a privately held company. Its leadership team includes Frédéric Banégas, COO and interim CEO, and Clémentine Liard, VP QARA and Chief of Staff.

• 2018

  Ganymed Robotics founded in France.

• Announced breakthrough in marker-less robotics for knee replacement surgery.

Developer of a unique robot-with-eyes platform for orthopedic joint replacement, aiming to set a new standard of care with faster, accurate, less invasive interventions.

• Robot-with-eyes platform

  A surgical robotics platform featuring a custom-designed co-manipulated arm with multimodal sensors to perceive and interpret the surgical scene, intended for orthopedic joint replacement.

1. 1Robotics For Orthopedics | Ganymed Roboticsganymedrobotics.com
2. 2ABOUT US | Ganymed Roboticsganymedrobotics.com
3. 3Ganymed Robotics - Wikidatawikidata.org